Ken-Wing Lee

4PUBLICATIONS
35CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 27, 2026
DISTINCT EPITOPE ENGAGEMENT CONFERS DIFFERENTIAL ACTIVITY OF LINVOSELTAMAB VERSUS TECLISTAMAB ACROSS BCMA MUTATIONS.

|Nov 09, 2022
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models.

Joyce Wei, Welby Montalvo-Ortiz, Lola Yu

|May 04, 2019
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.

Rajarsi Mandal, Robert M Samstein, Ken-Wing Lee

|Apr 24, 2019
Immunogenic neoantigens derived from gene fusions stimulate T cell responses.

Wei Yang, Ken-Wing Lee, Raghvendra M Srivastava

Pageof 1

Frequent Collaborators

2 joint publications

Timothy A Chan

2 joint publications

Luc Gt Morris

2 joint publications

Jonathan J Havel

2 joint publications

Fengshen Kuo